We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+7.02%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$4.22B
AUM Growth
-$873M
Cap. Flow
-$1.18B
Cap. Flow %
-28.02%
Top 10 Hldgs %
31.05%
Holding
110
New
22
Increased
26
Reduced
27
Closed
30

Top Buys

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$94.6M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$79.4M
3
ZBH icon
Zimmer Biomet
ZBH
+$78.6M
4
DVA icon
DaVita
DVA
+$74.5M
5
HOLX
Hologic
HOLX
+$69M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$103M
2
CNC icon
Centene
CNC
+$85.6M
3
AGN.PRA
Allergan plc
AGN.PRA
+$79.2M
4
JD icon
JD.com
JD
+$78.6M
5
ELV icon
Elevance Health
ELV
+$77.6M

Sector Composition

Rank Sector Weight
1 Healthcare 48.28%
2 Technology 12.7%
3 Communication Services 3.9%
4 Financials 3.09%
5 Consumer Discretionary 2.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSFT icon
51
Microsoft
MSFT
$2.84T
$27.1M 0.64%
316,941
-729,926
-70% -$59.9M
KURA icon
52
Kura Oncology
KURA
$922M
$26.8M 0.64%
1,752,124
-659,428
-27% -$9.72M
JNCE
53
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$26.6M 0.63%
2,087,224
+359,227
+21% +$5.28M
TSLA icon
54
Tesla
TSLA
$1.24T
$25.7M 0.61%
+1,240,500
New +$27M
RGNX icon
55
Regenxbio
RGNX
$623M
$25.6M 0.61%
+769,795
New +$23.2M
XYZ
56
Block Inc
XYZ
$45.9B
$25.6M 0.61%
738,276
+30,157
+4% +$1.1M
BLUE
57
DELISTED
bluebird bio
BLUE
$24.9M 0.59%
+10,792
New +$21.9M
TREE icon
58
LendingTree
TREE
$544M
$22.2M 0.53%
65,340
-21,642
-25% -$6.15M
HUM icon
59
CALL
Humana
HUM
$46.7B
$20.4M 0.48%
+82,200
New +$20.3M
ARAY icon
60
Accuray
ARAY
$28.4M
$18.8M 0.45%
4,376,578
+208,065
+5% +$955K
CUTR
61
DELISTED
Cutera, Inc.
CUTR
$18.8M 0.45%
414,815
-12,348
-3% -$521K
AMT icon
62
American Tower
AMT
$77.7B
$17.6M 0.42%
+123,478
New +$17.6M
ECYT
63
DELISTED
Endocyte, Inc. Common Stock
ECYT
$14.7M 0.35%
+3,441,594
New +$16.4M
SYNH
64
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$13.7M 0.32%
+313,257
New +$14.6M
ALNA
65
DELISTED
Allena Pharmaceuticals
ALNA
$13.3M 0.31%
+1,464,204
New +$18M
CSII
66
DELISTED
Cardiovascular Systems, Inc.
CSII
$13M 0.31%
549,657
+103,766
+23% +$2.62M
NITE
67
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
$12.8M 0.3%
979,393
+464,966
+90% +$8.36M
LCI
68
PUT
DELISTED
Lannett Company, Inc.
LCI
$12.1M 0.29%
+130,200
New +$12.7M
INGN icon
69
Inogen
INGN
$167M
$10.9M 0.26%
91,829
-149,228
-62% -$16.4M
COUP
70
DELISTED
Coupa Software Incorporated
COUP
$10.7M 0.25%
342,725
+340,788
+17,594% +$11.6M
IVTY
71
DELISTED
Invuity, Inc
IVTY
$6.78M 0.16%
1,092,979
+163,686
+18% +$1.33M
OPTN
72
DELISTED
OptiNose
OPTN
$6.1M 0.14%
+21,528
New +$6.06M
CMTA
73
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
$5.92M 0.14%
311,755
-25,446
-8% -$426K
AKRX
74
PUT
DELISTED
Akorn Inc
AKRX
$3.35M 0.08%
+104,000
New +$3.41M
META icon
75
Meta Platforms (Facebook)
META
$1.51T
$648K 0.02%
3,670
-584,616
-99% -$103M
1 2
3
4 5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return

PFM Health Sciences's Q4 2017 Portfolio in Review

As of Q4 2017, PFM Health Sciences held 110 positions worth $4.22B, down 17% from $5.09B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

PFM Health Sciences withdrew a net $1.18B in Q4 2017, closing 30 positions and reducing 27 holdings. Its most notable exit was Centene, an estimated $85.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, up from 33% a quarter earlier, followed by Technology and Communication Services.

Against the trend, PFM Health Sciences opened a new position in Baidu worth $90.7M.

  • PFM Health Sciences's largest Q4 2017 buy was Baidu: 387,046 shares worth $90.7M.
  • PFM Health Sciences added most to Puma Biotechnology in Q4 2017, an estimated $50.6M increase.
  • PFM Health Sciences's biggest Q4 2017 reduction was Meta Platforms (Facebook), cutting an estimated $103M.
  • PFM Health Sciences fully exited Centene in Q4 2017, selling an estimated $85.6M.
  • PFM Health Sciences's ten largest holdings make up 31% of its $4.22B portfolio in Q4 2017.
  • PFM Health Sciences opened 22 new positions and closed 30 in Q4 2017.
  • PFM Health Sciences's portfolio value fell 17% quarter-over-quarter to $4.22B.

Based on PFM Health Sciences's 13F filing for Q4 2017, filed 14 Feb 2018.